Editor’s note: A recording of the event is embedded above. A version of this recording with closed captioning can be found on our YouTube page here.
Europe’s largest cancer research meeting, the ESMO Virtual Congress, recently took place on Sept. 19-21. With the event behind us, STAT’s Adam Feuerstein will moderate a panel with some top cancer experts to review the significant data presented at ESMO, discuss what to expect for the rest of the year in cancer clinical trials, and take your questions.
Featured Speakers:
- Sponsor Introduction: Alexey Aleshin, M.D., M.B.A., medical director, oncology, Natera
- David S. Hong, M.D., professor and deputy chair of Investigational Cancer Therapeutics at the University of Texas MD Anderson Cancer Center
- Merry-Jennifer Markham, M.D., FACP, FASCO, professor and interim chief, University of Florida Division of Hematology and Oncology; associate director for medical affairs, UF Health Cancer Center
- Adam Feuerstein, senior writer, biotech, STAT (moderator)
About the Author Reprints
